Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00353470 · ClinicalTrials.gov registry record · Phase 3
Comparison of Psychotherapy Programs to Treat Panic Disorder
A Phase 3 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 3
- Development phase
- 201
- Enrollment target
NCT00353470: Completed Phase 3 study, sponsored by Weill Medical College of Cornell University.
NCT00353470 is a Phase 3 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 201 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00353470, a Phase 3 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 201 participants
- Enrollment target
Study Summary
This study will determine the relative effectiveness of three psychotherapies in treating people with a panic disorder.
Primary Outcome
A composite score of panic severity. High value = 28, lowest value =0. Higher=worse
Interventions
- BEHAVIORAL Cognitive behavioral therapy
- BEHAVIORAL Applied relaxation training (ART)
- BEHAVIORAL Panic focused psychodynamic psychotherapy (PFPP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2006-09 |
| Est. Completion | 2012-09 |
| Phase | Phase 3 |
What the finished NCT00353470 record still lists
NCT00353470 is an interventional study that assigns participants to a tested intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 3 interventions - of which Cognitive behavioral therapy is the first listed.
NCT00353470 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00353470 about?
NCT00353470 is a clinical study titled "Comparison of Psychotherapy Programs to Treat Panic Disorder". This study will determine the relative effectiveness of three psychotherapies in treating people with a panic disorder.
What is the current status of trial NCT00353470?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 201 participants. The study started on 2006-09. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00353470?
The interventions under investigation include: Cognitive behavioral therapy (BEHAVIORAL), Applied relaxation training (ART) (BEHAVIORAL), Panic focused psychodynamic psychotherapy (PFPP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00353470?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00353470's enrollment target sits among peer trials
201 1353rd of 2000 higher than 648 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia